PulmoDeep is an AI-powered diagnostic platform that detects lung diseases by analyzing medical images and patient data. It provides accurate early detection of conditions like pneumonia, tuberculosis, and lung cancer, offering timely triage recommendations and improving diagnostic precision to enhance patient outcomes.
Problem: Lung diseases are among the leading causes of death globally, with lung cancer alone responsible for approximately 1.8 million deaths annually, while conditions like pneumonia and tuberculosis contribute significantly to global mortality and morbidity. Due to complex symptoms and similar imaging presentations, these diseases face a high misdiagnosis rate—estimated to be around 20-30% in some cases. Misdiagnosis or delayed diagnosis not only contributes to advanced disease progression but also amplifies healthcare burdens and limits timely interventions, severely impacting patient survival rates and quality of life.
Approach: PulmoDeep leverages advanced AI algorithms to analyze medical images and integrate patient data, focusing on identifying disease markers indicative of early lung abnormalities. By training on extensive datasets, the platform refines its ability to recognize and differentiate between various lung conditions.
Solution: PulmoDeep delivers high-accuracy, AI-driven diagnostics that allow for early detection and precise triage recommendations for diseases like pneumonia, tuberculosis, and lung cancer. This approach enables timely interventions, ultimately improving diagnostic precision and supporting better patient outcomes through prompt and personalized care.